BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17653118)

  • 1. Percutaneous closure of a patent foramen ovale in left-sided carcinoid heart disease.
    Chaudhari PR; Abergel J; Warner RR; Zacks J; Love BA; Halperin JL; Adler E
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):455-9. PubMed ID: 17653118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale in carcinoid heart disease.
    Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
    Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
    Hayashi Y; McGaw DJ; Goldstein J
    Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of left atrial myxoma with ventricular septal defect and patent foramen ovale].
    Satokawa H; Iwaya F; Igari T; Watanabe M; Sato Y; Ogawa T; Hoshino S
    Kyobu Geka; 1993 Dec; 46(13):1126-8. PubMed ID: 8258918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of left-sided carcinoid heart disease.
    Connolly HM; Schaff HV; Mullany CJ; Rubin J; Abel MD; Pellikka PA
    Circulation; 2001 Sep; 104(12 Suppl 1):I36-40. PubMed ID: 11568027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature.
    Chowdhury MA; Taleb M; Kakroo MA; Tinkel J
    Echocardiography; 2015 Jan; 32(1):165-9. PubMed ID: 24976489
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
    Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
    Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous closure of a patent foramen ovale via left axillary vein approach with the Amplatzer Cribriform septal occluder.
    Carter LI; Cavendish JJ
    J Interv Cardiol; 2008 Feb; 21(1):28-31. PubMed ID: 18254787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.
    Boglioli LR; Gardiner J; Gerstenblith G; Taff ML; Cameron DE
    Tex Heart Inst J; 1997; 24(2):125-8. PubMed ID: 9205988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneurysmal and partially thrombosed orifice of a coronary artery fistula into the right atrium combined with patent foramen ovale.
    Preiss M; Habicht J; Bongartz G; Zerkowski HR
    Thorac Cardiovasc Surg; 2001 Apr; 49(2):120-1. PubMed ID: 11339449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic formation of the foramen ovale mimicking a right atrial myxoma.
    Seebacher G; Binder T; Frank H; Wolner E; Mohl W
    Ann Thorac Surg; 2006 Dec; 82(6):2296-8. PubMed ID: 17126161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual cause of cyanosis in a patient with a carcinoid tumor.
    Rodriguez-Cintron W; Gonzalez JM; Zoghbi W; Stevens PM
    South Med J; 1997 Oct; 90(10):1029-31. PubMed ID: 9347815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late perforation of right atrium and aortic root after percutaneous closure of patent foramen ovale.
    Palma G; Rosapepe F; Vicchio M; Russolillo V; Cioffi S; Vosa C
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1054-5. PubMed ID: 17903534
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A rare cause of exertional dyspnea in a 63-year-old woman].
    Miljak T; Birkemeyer R; Jung W
    Dtsch Med Wochenschr; 2007 Dec; 132(50):2699-701. PubMed ID: 18058661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Percutaneous left ventricular assist device complicated by a patent foramen ovale: importance of identification and management".
    Satler L
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):387. PubMed ID: 17722042
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting.
    Marenco J; Naimi S; Hijazi Z; Patel A; Pandian N
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):210-3. PubMed ID: 11025579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.